SIREUS’ Post

Various start-up clients have found funding much harder to come by over the last 12 months, with the life science investment market seemingly struggling. Are things starting to look up after the turn of the year? Goldman Sachs is targeting early to mid-stage therapeutic companies with multi-asset portfolios with one of the largest ever first-time private life science growth funds - $650M! #investment #VC #therapeutics #lifescience #biotechnology

Mr Ralf Brenner from GSK Stockmann discusses asset management trends in Germany 2024 in the 2024/25 edition of the International Asset Management & Investment Funds review. The publication will highlight important issues, key developments, and the latest trends within the global asset management industry. It will provide our global readership with a clear understanding of the opportunities within this industry and also within individual domestic markets. The full publican is free to download at: https://lnkd.in/d_KF3JsB #asset #assetmanagement #investmentfunds #funds #germany

Meet Patrice Bonfiglio, President of Sarissa Capital Management LP, a hedge fund focused on constructive shareholder activism in the healthcare sector. In addition, Ms. Bonfiglio serves as Chief Financial Officer of Sarissa Capital Acquisition Corp., a special purpose acquisition company focusing on the healthcare and biopharma industry. Patrice will be joined by Phillip Goldstein, Founder and CEO of Bulldog Investors to discuss Good, Bad and Ugly - Defining Shareholder Activism Success and Failure + When and how activism goes wrong and how to move forward + Ways shareholder activism helps propel stagnant companies into a brighter future + Case studies and situational analysis that help drive better decisions Early Rate Expires this Friday - Register: https://loom.ly/INImVrY #AcvtivistInvestorConference #ShareholderActivism

🚀 2024 is off to a thrilling start in the realm of #syntheticbiology ! Goldman Sachs Asset Management's massive $650M life sciences growth fund is making waves as one of the grandest first-time private funds in the sector. They've already invested about $90M in pioneering companies like TORL BioTherapeutics, LLC. 🌟 Amit Sinha's words resonate with me: "We are in a golden era of innovation in the life sciences." Marc Nachmann's insight is equally compelling, highlighting life sciences as a dynamic segment in the private investing world, driven by rapid technological advancements in healthcare. This surge in investment is a clear indicator that 2024 will be a landmark year for synthetic biology. We're set to witness extraordinary breakthroughs, challenging our existing limitations and shaping the future of healthcare, climate tech and beyond! #SyntheticBiology #FutureOfHealthcare #InnovationInvestment #GoldmanSachs #2024Trends https://lnkd.in/eGVSEynC

In this exclusive episode of Big Boss Big Idea, GEETU MOZA, Consulting Editor at Jagran Business, interviews Aditya Khemka, Fund Manager at InCred Asset Management. They discuss the potential of Pharma shares and explore the factors that could impact this sector's growth. Gain insights into the pharma market and understand where the opportunities lie for investors. Watch till the end for expert advice on investing in Pharma stocks! Key Topics: - Pharma sector insights - Investment strategies for Pharma stocks - Growth potential and risks in the Pharma industry

This week at the NextGen Symposium, our cohort of aspiring and emerging Fund Managers will learn from experts at Kirkland & Ellis about the critical components of structuring a firm. David Lenzi and Laura Stake will cover topics including: - Fund and sponsor structuring - Fund documentation - Marketing considerations - The closing process Lear more about this session and the NextGen Sympoisum: https://lnkd.in/eCPsPfPa #alternativeinvestments #fundmanagement #assetmanagement

GeoWealth Closes $18 Million Growth Investment Led by BlackRock Learn more & get our take 👇 https://lnkd.in/gYCztCPa "We’re thrilled to enter this next phase of our growth journey with the backing of BlackRock as a strategic partner and investor. As we continue to invest in our proprietary technology, we will build new offerings that provide RIAs with a flexible, customizable and user-friendly platform." — Colin Falls, Chief Executive Officer at GeoWealth "RIAs are in the DNA of GeoWealth. This investment and partnership emphasize our commitment to continual innovation for the benefit of RIAs, delivering more scalability, flexibility, customization and exceptional service." — Jack Hannah, President & Chief Operating Officer at GeoWealth #funding #finance #SoFNews

Register for a webinar on 12th September at 10.30am with Carlos Moreno, Fund Manager of the Premier Miton European Opportunities Fund, where he will discuss recent market activity, provide an update on the fund on and its positioning, and share where the team are currently seeing opportunities. For Investment Professionals only. Capital at Risk. Premier Miton Investors #europe #europeanopportunities #europeanequities #webinar #investing

💡 Read the VC Executive Insights from Hubert Birner in In Vivo ( Pharma Intelligence, now Citeline )📰   Hubert spoke with Lucie Ellis-Taitt to discuss the TVM investment strategy and share his insights into expectations for the European life science sector in 2024: “there's a lot of opportunity [for investors] out there.” But in 2024 “companies need to adjust their business plans so that they can hit value enhancing milestones with limited available capital.” Read the full article here (paywall): https://lnkd.in/eMRPpPja #VC #EuropeanLifeScience #mergersandacquisitions

🚨The Most-Read Deal Today: Evercore Has Completed Sole Advisory on 21 Invest's €500m ProductLife Group Continuation Fund - Deal Summary Krugman Insights offers Reliable and Comprehensive Insights across M&A, Investment Banking, Private Equity, and Asset Management. 🔎 Financial Advisor on the Deal: Evercore PCA 🔎 Legal Advisor on the Deal: Clifford Chance 🔎 Key Stakeholders: 21 Invest France, ProductLife Group, Oakley Capital 💡21 Invest France has successfully sold ProductLife Group (PLG) to a newly established continuation fund managed jointly with Oakley Capital. Valued at €500 million. The new fund, supported by investments from Eurazeo, Hayfin Capital Management LLP, Arcano, Indosuez Wealth Management, and Goldman Sachs Alternatives, will further propel PLG’s ambitious plans. ✅ FULL ARTICLE HERE: https://lnkd.in/eKP8tRJf ✅ TRY 30 DAYS FREE: https://lnkd.in/eBHYx37M #Evercore #OakleyCapital #21InvestFrance #ProductLifeGroup #MergersAndAcquisitions #InvestmentBanking #CorporateFinance #FinancialAdvisory